Clinical Trials in Illinois

Showing 16601-16620 of 19,692 trials

Project FARMS: Fall Risk Reduction in Multiple Sclerosis

NCT01837017

Over half of persons with multiple sclerosis (MS) report falling over a 6-month period and a majority of those who fall require medical attention for injuries. Importantly, balance dysfunction, muscle weakness, and spasticity are modifiable risk factors for falls among community-dwelling older adults and likely persons with MS. Indeed, there is evidence that these physiological risk factors can be minimized with exercise training in persons with MS and this might translate into a decrease in fall risk as documented in community-dwelling older adults. The investigation will examine the effectiveness of a home-based exercise program that is designed to reduce fall risk by targeting specific fall risk factors including balance dysfunction and two of its latent causes, muscle weakness and spasticity in persons with multiple sclerosis. It is predicted that persons who receive home-based exercise program will have a reduction in fall risk.

Multiple Sclerosis

University of Illinois at Urbana-Champaign33 participantsStarted Jun 2012

Urbana, Illinois, United States

COMPLETED94 miles

CARTO® 3 System and Real Time Intracardiac Ultrasound

NCT01716663

This is a prospective, multicenter, non-randomized observational study of subjects 18 years and older undergoing RF ablation with drug refractory recurrent symptomatic paroxysmal Atrial Fibrillation (AF).

Atrial FibrillationParoxysmal AF

Biosense Webster, Inc.234 participantsStarted Oct 2012

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Santa Barbara, California, United States +23 more locations

Project FARMS: Fall Risk Reduction in Multiple Sclerosis

CARTO® 3 System and Real Time Intracardiac Ultrasound

Find Trials by Condition in Illinois

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Expanded Dryvax Dilution Study in Previously Vaccinated Adults

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Gene Therapy for Tay-Sachs Disease

Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)

Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen

Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer

Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

EU/LA Pearl Index Study - Transdermal Contraceptive Patch